CPRX icon

Catalyst Pharmaceutical

16 hedge funds and large institutions have $5.01M invested in Catalyst Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Federated Hermes
1
Federated Hermes
Pennsylvania
$3.59M 4,034,207 +4,034,207 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$494K 555,585 +555,585 New
SC
3
Sophrosyne Capital
New York
$458K 510,000 +510,000 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$147K 165,418 +165,418 New
TCM
5
Tanaka Capital Management
New York
$107K 147,993 +147,993 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$41K 46,438 +46,438 New
Northern Trust
7
Northern Trust
Illinois
$38K 42,906 +42,906 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$37K 41,332 +41,332 New
Bank of America
9
Bank of America
North Carolina
$20K 22,112 +22,112 New
U
10
UBS
Switzerland
$16K 18,138 +18,138 New
Citadel Advisors
11
Citadel Advisors
Florida
$15K 16,861 +16,861 New
CA
12
CapWealth Advisors
Tennessee
$12K 13,000 +13,000 New
CS
13
Credit Suisse
Switzerland
$12K 13,899 +13,899 New
GC
14
Guggenheim Capital
Illinois
$11K 12,304 +12,304 New
Creative Planning
15
Creative Planning
Kansas
$8K 9,455 +9,455 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$2K 2,000 +2,000 New